MORE►
Nanoscope
Paul Hallen will oversee Nanoscope's global operations, including commercial readiness, supply chain, and cross-functional execution, as the company works toward regulatory approval and launch of MCO-010 (MOGENRY), a therapy developed to treat retinitis pigmentosa.
Nanoscope Therapeutics Names Former Alcon Exec as Its New COO
by Sandra Engelland | Apr 2, 2026
Paul Hallen will oversee Nanoscope's global operations, including commercial readiness, supply chain, and cross-functional execution, as the company works toward regulatory approval and launch of MCO-010 (MOGENRY), a therapy developed to treat retinitis pigmentosa.
by Dallas Innovates | Staff Report |
Dec 10, 2025
Dallas-Fort Worth ranked No. 9 for patent activity out of 250 metros for the week of Nov. 4 with a total of 156 patents granted.
MORE►
by Lance Murray |
May 17, 2024
Khandan Baradaran, PhD, was most recently VP of regulatory CMC at Ultragenyx Pharmaceutical, a biopharmaceutical company involved in the research and development of novel products for the treatment of rare and ultra-rare genetic diseases.
MORE►
by Lance Murray |
Apr 26, 2024
Dallas-based Nanoscope said Dr. Allen C. Ho will help define the strategy of developing its gene mutation-agnostic therapies. Ho is attending surgeon and director of retina research at Wills Eye Hospital and co-director of the Wills Eye Hospital Retina Service.
MORE►
[Photo: Ekkasit919/istockphoto]
Frisco-based Ever.Ag Adds Ex-General Mills Exec to Board of Directors
by Lance Murray | Nov 9, 2022
Ever.Ag, a Frisco-based AgTech supply chain software and financial services company, announced that it has added former General Mills executive John Church as an independent member to its board of directors.
“John has a deep understanding of the agricultural supply chain and how key stakeholders, including cooperatives, producers, and CPGs, can work together successfully....
MORE►
by Lance Murray |
Apr 8, 2022
In this week's roundup of hires, promotions, and accolades in North Texas, you'll also find news from Firehouse, Enseo, Cambium Learning, D Magazine, Lear Investment Management, Spacee, Envy Gaming, 5Q, Stream Realty Partners, Nanoscope, Crossplane Capital, Improving, TimelyMD and more.
MORE►
by Alex Edwards |
Sep 14, 2021
The Bedford-based biotech will use the capital from the National Eye Institute of the National Institutes of Health to advance its gene therapy that treats age-related macular degeneration.
Earlier this summer, Nanoscope Therapeutics announced it successfully treated 11 patients who were blinded by advanced retinitis pigmentosa.
Earlier this summer, Nanoscope Therapeutics announced it successfully treated 11 patients who were blinded by advanced retinitis pigmentosa.
MORE►
by Lauren Hawkins |
Jul 21, 2020
Nanoscope Therapeutics, a TechFW client, has closed an over-subscribed Series A funding round for its leading work on retinas, which could enable the blind to see.
In addition, Nanoscope has named Al Guillem as Chairman of the Board. Guillem (pictured below) was part of TechFW's greatest success story when ZS Pharma, a company he co-founded, was purchased by AstraZeneca for $2.7 billion.
In addition, Nanoscope has named Al Guillem as Chairman of the Board. Guillem (pictured below) was part of TechFW's greatest success story when ZS Pharma, a company he co-founded, was purchased by AstraZeneca for $2.7 billion.
MORE►
[Illustration: blackdovfx/istockphoto]
Follow the Money: Nanoscope Gets $4M, Integrity Bio-Chem Raises $2.9M, Keurig Dr Pepper to Buy Core
by Lance Murray | Sep 27, 2018
From Nature Nate's to SunTX Capital Partners and Anchor Partners and Wisteria, here are funding and M&A deals involving companies and investors with North Texas ties
MORE►
